Alison Kurimchak

774 citations
21 papers · 541 indexed · h-index 14
Topics
Ubiquitin and proteasome pathways (13 papers)Cancer-related Molecular Pathways (8 papers)Microtubule and mitosis dynamics (7 papers)

In The Last Decade

Alison Kurimchak

21 papers receiving 539 citations

Peers

Alison Kurimchak
Comparison fields: 5 of 65
  • Molecular Biology 439
  • Oncology 186
  • Hematology 81
  • Cancer Research 74
  • Cell Biology 68
Replace Danrui Cui with:
Danrui Cui China
Ayaka Koike Japan
María Guillamot United States
Florian Bellutti Austria
Jayant K. Rane United Kingdom
Luigi Alfano Italy
Marc Payton United States
Uwe Eberspächer Germany
Ernest Medina United States
Jeffrey Patterson-Fortin United States
Alison Kurimchak relative to Danrui Cui China Danrui Cui's profile →
Citations per field
00.5×10×15×18×
Danrui Cui · 1×
Citations per year

Countries citing papers authored by Alison Kurimchak

Since Specialization
Citations

This map shows the geographic impact of Alison Kurimchak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Kurimchak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Kurimchak more than expected).

Fields of papers citing papers by Alison Kurimchak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Kurimchak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Kurimchak. The network helps show where Alison Kurimchak may publish in the future.

Co-authorship network of co-authors of Alison Kurimchak

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Kurimchak. A scholar is included among the top collaborators of Alison Kurimchak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Kurimchak. Alison Kurimchak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 5
4 3
5 2
6 27
7 64
8 6
9 23
10 19
11 18
12 25
13 22
14 143
15 30
16 23
17 43
18 25
19 11
20 16

About Alison Kurimchak

Alison Kurimchak is a scholar working on Oncology, Cell Biology and Hematology, having authored 21 papers that have together received 541 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Cancer-related Molecular Pathways (8 papers) and Microtubule and mitosis dynamics (7 papers). The work is most often cited by research in Hematology (81 citations), Oncology (186 citations) and Molecular Biology (439 citations). Alison Kurimchak has collaborated with scholars based in United States, Russia and Sweden. Frequent co-authors include Xavier Graña, James S. Duncan, Jonathan Chernoff, Kelly Duncan, Claude Shelton, Judit Garriga, Denise C. Connolly, Shane W. O’Brien, Elena Sotillo and Rashid Gabbasov. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026